Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002

Epidemiology and Infection

Volumn 134, Issue 1, 2006, Pages 103-110

  Smith, Ingrid ^a   Bjoornevik A T ^a   Augland, I M B ^a   Berstad, A ^b   Wentzel Larsen, T ^b   Halstensen, A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; MANNITOL; PENICILLIN G; VASOPRESSIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GROUP TYPING; CHILD; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; ECCHYMOSIS; FATALITY; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENINGITIS; MENINGOCOCCOSIS; MULTIVARIATE ANALYSIS; NEISSERIA MENINGITIDIS; NIGHT; NORWAY; PETECHIA; RASH; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEASONAL VARIATION; SEPTICEMIA; SYMPTOMATOLOGY; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; HYPOTENSION; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NORWAY; PATIENT ADMISSION; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 30844442820     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268805004553     Document Type: Article

References (30)

1. Bøvre K, Gedde-Dahl TW. Epidemiological patterns of meningococcal disease in Norway 1975-1979. NIPH Ann 1980; 3: 9-22.
2. Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975-91. NIPH Ann 1991; 14: 57-65.
3. Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992-1995. Epidemiology and fatality. Scand J Infect Dis 1996; 28: 253-259.
4. Halstensen A, Pedersen SH, Haneberg B, Bjorvatn B, Solberg CO. Case fatality of meningococcal disease in western Norway. Scand J Infect Dis 1987; 19: 35-42.
5. Bjune G, Hoiby EA, Gronnesby JK, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991; 338: 1093-1096.
6. Bjune G. One for all - all for one. A survey on the recruitment in junior high schools to the meningococcal vaccine trial 1988-1989. In: Sundelin F, ed., Health Services Research. Oslo, Norway: National Institute of Public Health, 1991; 23-34.
7. Gedde-Dahl TW, Høiby EA, Schillinger A, Lystad A, Bøvre K. An epidemiological, clinical and microbiological follow-up study of incident meningococcal disease cases in Norway, winter 1981-1982. Material and epidemiology in the MenOPP project. NIPH Ann 1983; 6: 155-168.
8. Connolly M, Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiol Infect 1999; 122: 41-49.
9. Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J 1989; 8: 8-11.
10. Jensen ES, Schønheyder HC, Lind I, Berthelsen L, Nørgard B, Sørensen HT. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: A 20-year population-based historical follow-up study in a Danish county. J Med Microbiol 2003; 52: 173-179.
11. Berg S, Trollfors B, Alestig K, Jodal U. Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989. Scand J Infect Dis 1992; 24: 333-338.
12. Halstensen A, Aase I, Bjørnevik AT, Smith I. Reduced case fatality rate of meningococcal disease after public information about the early signs of meningococcal septicaemia. In: Halstensen AI, Bjørnevik AT, Smith I, eds. Twelfth International Pathogenic Neisseria Conference. Galveston, Texas, USA: Health Care Communications, Inc., 2000: 99, no. 326.
13. Riordan FA, Thomson AP. Early presentation of meningococcal disease after media publicity. Arch Dis Child 1993; 69: 711.
14. Cartwright KA. Early management of meningococcal disease. Infect Dis Clin North Am 1999; 13: 661-684.
15. Stephens DS. Uncloaking the meningococcus: Dynamics of carriage and disease. Lancet 1999; 353: 941-942.
16. Smith I, Lehmann AK, Lie L, et al. Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiol Infect 1999; 123: 373-382.
17. Spanjaard L, Bol P, de Marie S, Zanen HC. Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83. Bull World Health Organ 1987; 65: 861-868.
18. Whalen CM, Hockin JC, Ryan A, Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. J Am Med Assoc 1995; 273: 390-394.
19. Jones D. Epidemiology of meningococcal disease in Europe and the USA. In: Cartwright K, ed. Meningococcal disease. New York: John Wiley & Sons Ltd, 1995: 147-157.
20. Scholten RJ, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningococcal disease: A multivariate analysis. Epidemiol Infect 1994; 112: 115-124.
21. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999; 180: 1894-901.
22. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: Results of a 5-year population-based study. Ann Intern Med 1995; 123: 937-940.
23. Shigematsu M, Davison KL, Charlett A. Crowcroft NS. National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001. Epidemiol Infect 2002; 129: 459-470.
24. Moe PJ. Meningococcal disease - treatment of patients and household contacts below the age of 15 years. NIPH Ann 1980; 3: 95-99.
25. Lystad A. Principles and practice of control of meningococcal disease in Norway. NIPH Ann 1980; 3: 103-107.
26. Booy R, Habibi P, Nadel S, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85: 386-390.
27. Thorburn K, Baines P, Thomson A, Hart CA. Mortality in severe meningococcal disease. Arch Dis Child 2001; 85: 382-385.
28. Niklasson PM, Lundbergh P, Strandell T. Prognostic factors in meningococcal disease. Scand J Infect Dis 1971; 3: 17-25.
29. van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-166.
30. Goldacre MJ, Roberts SE, Yeates D. Case fatality rates for meningococcal disease in an English population, 1963-98: Database study. Br Med J 2003; 327: 596-597.